However buy generic pirfenex 200 mg, ms associated to fluorquinolones should be limited purchase generic pirfenex on line, since there is less consensus regarding which drug belonging this both groups of antibiotics activate common resistance family should be prescribed order pirfenex 200mg without prescription. While some authors consider mechanisms thus favoring the appearance of resistances the natural and semisynthetic penicillins (amoxicillin) to in important pathogens such as Pseudomona aeruginosa and be the options of first choice (22), others prefer the asso- Acinetobacter spp (26). In the tertiary period a first treatment infections of the mucosal membranes, muscles and fascias, is provided with intravenous penicillin G, followed by penicillin salivary glands and bone. Bone infections are included here G benzatine via the intramuscular route once a week during 3 on the grounds that many of them may be of dental origin. Prophylaxis of local infection is taken to comprise the ad- Firstly, transient bacteremia occurs not only after dental ministration of antibiotics on a pre-, intra- or postoperative treatments such as extractions (35-80%) or periodontal basis, to prevent bacterial proliferation and dissemination surgery (30-88%). Few clinical studies to hing (40%) or while chewing gum (20%), and is proportional date have evaluated this type of treatment. Some authors have to the trauma caused and to the number of germs coloni- reported its efficacy, with statistically significant differences in zing the affected zone. Secondly, not only bacteria cause the frequency of infectious complications in surgical extrac- endocarditis, and of those that do cause the disease, many tions of lower third molars between patients who had received are resistant to the antibiotics administered as prophylaxis some form of antibiotic treatment and those without (34). Lastly, it is known that most In a retrospective study of infections following periodontal surgery cases of bacterial endocarditis are not related with invasive in 390 patients and involving 1053 surgical procedures carried out procedures, and that dental care is only responsible for a by Powell et al. Howe- The authors therefore did not consider it to be justified to administer ver, the results of a survey conducted by Tomas-Carmona et antibiotics on a postoperative basis with the sole purpose of avoiding al. In a consensus document on the use of antibiotic pro- There is no scientific basis for recommending systematic phylaxis in dental surgery and procedures published in 2006 antibiotic prophylaxis prior to invasive dental treatment in (36), prophylaxis in oral surgery in a healthy patient was patients with total joint prostheses (31). In 30 of the patients he detected infection of the pros- grafting and surgery for benign tumors. In subjects with risk thesis, and in only one case was a time relationship with prior factors for local or systemic infection - including oncologi- dental treatment established. Furthermore, 54% of the germs cal patients, immune suppressed individuals, patients with isolated were Staphylococcus aureus and epidermidis (32). Dose adjustment of antibiotics most commonly used in dental practice, in patients with chronic kidney failure, according to creatinine clearance. Dose with creatinine Dose with creatinine Drug Normal dose clearance clearance <10 ml/min. Amoxicillin 500/1000 mg/8h Every 8-12 h Every 12-14 h Amoxicillin- 500-875 mg/8h Every 8 hours Every 12-24 hours clavulanate Clindamycin 300 mg/8h No adjustment needed No adjustment needed Doxycycline 100 mg/24h No adjustment needed No adjustment needed Erythromycin 250-500 mg/6h No adjustment needed No adjustment needed Metronidazole 250-500 mg/8h Every 8-12 hours Every 12-24 hours 50-100% of the dose 25-50% of the dose Penicillin G 0. In patients with liver failure, the use drug risk during pregnancy: (A) without demonstrated risk; of such antibiotics should be restricted in order to avoid (B) without effects in animals, though with undemonstrated toxicity secondary to overdose. As a result, and whenever possible, final group (X) in turn contemplates teratogenic effects that they should be avoided in patients with some active liver outweigh any possible benefit derived from the drug. Specifically, tetracyclines and anti-tuberculosis No antibiotic corresponds to group A. Grupos teraputicos de mayor consumo en el Sistema nacional de includes clarithromycin, the fluorquinolones and the sulfa Salud durante 2004. Medicine Many antibiotics are actively eliminated through the ki- 2006;9:3196-203. American Dental Association; American Academy of Orthopedic centration of amoxicillin and on staphylococcal infection. Alterations in cefalosporin levels in the serum and mandible of placebo for infectious and inflammatory morbidity after third molar hyperlipaedemic rats after co-administration of ibuprofen. Antibiotic therapy--managing odontogenic patient with end-stage liver disease and the liver transplant patient. Past administration of beta-lactam antibiotics and increase in the emergence of beta-lactamase-producing bacteria in patients with orofacial odontogenic infections. Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontognicas. Concentrations of azidocillin, erythromycin, doxycycline and clindamycin in human mandibular bone. Squeezing the antibiotic balloon: the impact of antimicro- bial classes on emerging resistance. Prevention of bacterial endocarditis: recommendations by the American Heart Association. Chemoprophylaxis of bac- terial endocarditis recommended by general dental practitioners in Spain. A variety of microorganisms were elucidated to cause infectious diseases in the latter half of the 19th century. Thereafter, antimicrobial chemo- therapy made remarkable advances during the 20th century, resulting in the overly optimistic view that infectious diseases would be conquered in the near future. However, in response to the development of antimicrobial agents, microorganisms that have acquired resistance to drugs through a variety of mechanisms have emerged and continue to plague human beings. In Japan, as in other countries, infectious diseases caused by drug- resistant bacteria are one of the most important problems in daily clinical practice. In the current situation, where multidrug-resistant bacteria have spread widely, options for treatment with antimicrobial agents are limited, and the number of brand new drugs placed on the market is decreasing. Since drug-resistant bacteria have been selected by the use of antimicrobial drugs, the proper use of currently available antimicrobial drugs, as well as efforts to minimize the transmission and spread of resistant bacteria through appropriate infection control, would be the rst step in resolving the issue of resistant organisms. In addition, in a situation where multidrug-resistant organisms Antimicrobial drugs have caused a dramatic have spread widely, there may be quite a limited change not only of the treatment of infectious choice of agents for antimicrobial therapy. Antimicrobial present, fewer brand new antimicrobial agents chemotherapy made remarkable advances, result- are coming onto the market. Considering this ing in the overly optimistic view that infectious situation together with the increasing awareness diseases would be conquered in the near future. Infections with drug- This paper provides an outline of the history resistant organisms remain an important problem of antimicrobial agents, and thereafter describes in clinical practice that is difcult to solve. This article is a revised English version of a paper originally published in the Journal of the Japan Medical Association (Vol. The antibiotic was named penicillin, infectious diseases have accounted for a very large and it came into clinical use in the 1940s. Accordingly, During the subsequent two decades, new classes chemotherapy aimed at the causative organisms of antimicrobial agents were developed one after was developed as the main therapeutic strategy. He nalidixic acid, a quinolone antimicrobial drug, found that the growth of Staphylococcus aureus was obtained in 1962. Second-generation cephems (cefotiam, Penicillins were originally effective for Gram- etc. Later, to that covers not only Gram-positive but also Gram- address penicillin-resistant S. Cephems were developed in the 1960s, and Carbapenem is an antibiotic class including came into widespread use. The In contrast, noroxacin, which came to market monobactam antibiotic aztreonam exerts an anti- in 1984, maintains a stable metabolic state and microbial effect only on Gram-negative bacteria. Its antimicro- Continuing improvements have been made for bial spectrum is extensive, covering both Gram- antimicrobial agents in various aspects in addi- positive and Gram-negative bacteria including tion to the antimicrobial spectrum and activity. Quinolone antimicrobials developed The drugs have been developed to achieve better after noroxacin have been called new quinolones, pharmacodynamics including the absorption of and they have still been key drugs.
Pre-transplant screening can identify people at high risk for developing diabetes 3 purchase genuine pirfenex on-line. Individuals undergoing total pancreatectomy for benign pancreatic disease may be considered for islet autotransplantation to prevent the (54) cheap pirfenex uk, but is not performed routinely in most transplant centres (4) buy cheap pirfenex 200 mg line. Be treated to individualized glycemic targets [Grade D, Consensus] glycemia and weight gain, it may be the preferred agent in the acute b. Receive healthy behaviour interventions similar to those recom- mended for people with type 2 diabetes [Grade D, Consensus] setting, particularly in the face of high-dose steroids with marked c. Receive insulin for metabolic decompensation or symptomatic/ severe hyperglycemia [Grade D, Consensus]. Metformin would seem a sensible rst- Denition, Classication and Diagnosis of Diabetes, Prediabetes line agent, assuming adequate renal reserve and hepatic function. S10 Adequate renal reserve would be required for a glucagon-like poly- Monitoring Glycemic Control, p. S115 inhibitors should be carefully considered (see Pharmacologic Gly- cemic Management of Type 2 Diabetes in Adults chapter, p. Author Disclosures Insulin secretagogues have risks of hypoglycemia and weight gain, and have inferior durability (which is often attributed to Dr. Senior reports personal fees from Abbott, Boehringer accelerated progression of beta cell decline) (62). AlMehthel reports personal fees from Novo Nordisk, Transplantation in People with Pre-Existing Diabetes outside the submitted work. References No controlled studies have examined treatment strategies for gly- cemic management after transplantation in people with pre- 1. Five-year follow-up after clinical islet trans- Institute of Diabetes and Digestive and Kidney Diseases, 2013. Glucose homeostasis and insulin (-Score greater than 7) is required to abrogate hyperglycemia, whereas a minimal secretion in human recipients of pancreas transplantation. Diabet Med 2009;26:617 kidney transplantation with primary function of at least one yeara single- 21. Improved patient survival with simul- ecacy, and cost of islet versus pancreas transplantation in nonuremic patients taneous pancreas and kidney transplantation in recipients with diabetic end- with type 1 diabetes. Combined pancreas-kidney trans- years by autoislet transplantation after pancreatectomy for chronic pancreati- plantation for patients with end-stage nephropathy caused by type-2 diabetes tis. Improvement of nerve conduction in dia- islet autotransplantation after 50% to 60% distal partial pancreatectomy for benign betic neuropathy. Improved survival in patients with insulin- transplantation, compared to oral antidiabetic agents, after distal pancreatec- dependent diabetes mellitus and end-stage diabetic nephropathy 10 years after tomy. Epidermal innervation in type 1 diabetic cell mass in selected patients with chronic pancreatitis and diabetes mellitus patients: A 2. Pancreas transplant alone deter- after kidney transplantation: Limitations of fasting glucose and advantages of mines early improvement of cardiovascular risk factors and cardiac function in afternoon glucose and glycated hemoglobin. Post-transplant diabetes mellitus: Causes, vascular disease in patients with type 1 diabetes. Impact of simultaneous pancreas and kidney for new-onset diabetes after kidney transplantation. Diabetes Care transplantation on cardiovascular risk factors in patients with type 1 diabetes 2013;36:28816. Long-term outcomes after organ transplan- glycosylated hemoglobin in the screening for diabetes mellitus after renal trans- tation in diabetic end-stage renal disease. Mortality in diabetes: stratify for new-onset diabetes after transplantation: An underdiagnosed phe- Pancreas transplantation is associated with signicant survival benet. Health-related quality of life may improve be performed routinely in all renal transplant recipients? Islet transplantation as a treatment for diabetesa work in prog- new onset diabetes after transplantation. Phase 3 trial of transplantation of human sitagliptin treatment in long-term stable renal recipients with new-onset dia- islets in type 1 diabetes complicated by severe hypoglycemia. Can J Diabetes 42 (2018) S150S153 Contents lists available at ScienceDirect Canadian Journal of Diabetes journal homepage: www. Commercial drivers should undergo an assessment at the time of application for a commercial license and as per provincial requirements thereafter. They should also identify For many Canadians, driving is an essential part of daily living and inform individuals with diabetes at higher risk for motor vehicle accidents. As the presence and extent of these factors drate, such as dextrose tablets, within easy reach inside the vehicle and carry your glucose meter and supplies. Older studies may and at least every 2 hours while driving or wear a real-time continu- no longer be as relevant due to changes in road conditions, vehicles ous blood glucose monitoring device. If your blood glucose is less than 4 mmol/L, do not start driving until Unrecognized hypoglycemia is the most relevant driving hazard you have ingested 15 grams of carbohydrate, you have retested and for drivers with diabetes. A number of studies have examined driving your blood glucose is at least 5 mmol/L. It is suggested to wait for 40 performance with a driving simulator during induced hypoglyce- minutes as it takes time for judgment and reexes to the brain to recover fully from hypoglycemia. Studies in type 1 If hypoglycemia develops while driving, stop the vehicle in a diabetes have demonstrated that performance starts to deterio- safe location and remove the keys from the ignition. The ability of deciding when it is safe to drive may be unreliable or absent Conict of interest statements can be found on page S152. However, studies have strated that cognitive function may not recover until 40 minutes demonstrated limited patient awareness of and adherence to rec- or more after restoration of euglycemia (710). A survey in Edinburgh of 202 drivers with insulin-treated alone, nor is it a problem for drivers with diabetes treated with diabetes showed only 50% of drivers reported following minimum most noninsulin antihyperglycemic medications, when used as safe driving recommendations: carrying carbohydrate in the vehicle, monotherapy or in combination with each other. Treatment with measuring glucose before a journey, stopping the vehicle during a insulin secretagogues (sulfonylureas, meglitinides) may provoke hypoglycemic episode and recognizing a low glucose as unsafe to higher rates of hypoglycemia when used alone or in combination drive (22). In a large multinational study, only 52% of drivers with type 1 of motor vehicle accidents in drivers with diabetes have consis- diabetes and 27% with type 2 diabetes had discussed driving guide- tently described the highest rates for individuals treated with insulin lines with their physician (13). A study in Finland indicated specically addressed differences between episodes during waking that among private and commercial drivers treated with insulin with hours and while asleep. Impaired awareness of hypoglycemia is also self-reported recurrent severe hypoglycemia, 68% continued to hold a signicant risk factor for severe hypoglycemia (19). Use of a memory glucose meter is recommended so that measurements can be assessed by Currently, 10 Canadian provinces and territories have a man- the health-care team and by driving authorities, if indicated. Those scoring in the upper quartile reported more who have conditions that impair their driving ability (29) (Table 1). Table 1 No studies have examined the effect of hyperglycemia on driving Canadian regulations for reporting medically unt drivers performance. Province/territory Reporting* Commercial Driving Alberta Discretionary British Columbia Mandatory (only if the driver has been warned of the dangers of driving and The risk for commercial vehicle drivers is higher than that for still continues to drive) private drivers as the former are on the road many hours of the day Manitoba Mandatory or night, thus increasing their time exposure. The consequences of New Brunswick Mandatory a motor vehicle accident involving a commercial vehicle are also Newfoundland and Labrador Mandatory likely to be more serious, particularly if the vehicle carries passen- Northwest Territories Mandatory Nova Scotia Discretionary gers or dangerous goods.
The hind legs of the ea pirfenex 200 mg fast delivery, for exam- ple pirfenex 200mg with amex, also contain resilin buy 200mg pirfenex mastercard, which stores energy for jumping (see Exercise 6-3). Compute the force on the body of the insect that must be generated during the downward wing stroke to keep the insect hovering. Referring to the discussion in the text, compute the point of attachment to the wing of muscle B in Fig. Assume that the shape of the resilin in each leg of the ea is equivalent to a cylinder 2 102 cm long and 104 cm2 in area. If the change in the length of the resilin is 102 cm, calculate the energy stored in the resilin. How large would these pads have to be in order for them to store 1 enough energy for a m jump? In the next three chapters, we will discuss the behavior of liquids and gases, both of which play an important role in the life sci- ences. The dierences in the physical properties of solids, liquids, and gases are explained in terms of the forces that bind the molecules. In a solid, the molecules are rigidly bound; a solid therefore has a denite shape and vol- ume. The molecules constituting a liquid are not bound together with su- cient force to maintain a denite shape, but the binding is suciently strong to maintain a denite volume. Therefore a gas has neither a denite shape nor a denite volumeit completely lls the vessel in which it is contained. Fluids and solids are governed by the same laws of mechan- ics, but, because of their ability to ow, uids exhibit some phenomena not found in solid matter. In this chapter we will illustrate the properties of uid pressure, buoyant force in liquids, and surface tension with examples from biology and zoology. When a force is applied to one section of a solid, this force is transmitted to the other parts of the solid with its direction unchanged. Because of a uids ability to ow, it transmits a force uniformly in all directions. A uid in a container exerts a force on all parts of the container in contact with the uid. The pressure in a uid increases with depth because of the weight of the uid above. In a uid of constant density, the dierence in pressure, P2 P1, between two points separated by a vertical distance h is P2 P1 gh (7. The relationship between the torr and several of the other units used to measure pressure follows: 1 torr 1mmHg 13. Because the pressure throughout the uid is the same, the force F2 acting on the area A2 in Fig. There are, however, soft-bodied animals (such as the sea anemone and the earthworm) that lack a rm skeleton. For the purpose of understanding the movements of an animal such as a worm, we can think of the animal as consisting of a closed elastic cylinder lled with a liquid; the cylinder is its hydrostatic skeleton. The worm pro- duces its movements with the longitudinal and circular muscles running along the walls of the cylinder (see Fig. Because the volume of the liquid in the cylinder is constant, contraction of the circular muscles makes the worm thinner and longer. Contraction of the longitudinal muscles causes the animal to become shorter and fatter. If the longitudinal muscles contract only on one side, the animal bends toward the contracting side. By anchoring alternate ends of its body to a surface and by producing sequential longitudinal and cir- cular contractions, the animal moves itself forward or backward. Assume that the circular muscles running around its circumference are uniformly distributed along the length of the worm and that the eective area of the muscle per unit length of the worm Section 7. The force Ff in the forward direction generated by this pressure, which stretches the worm, is 2 4 Ff P r 1. We will now use Archimedes principle to calculate the power required to remain aoat in water and to study the buoyancy of sh. If its density is greater than that of water, the animal must perform work in order not to sink. We will calculate the power P required for an animal of volume V and density to oat with a fraction f of its volume submerged. This motion accelerates the water downward and results in the upward reaction force that supports the animal. If the area of the moving limbs is A and the nal velocity of the accelerated water is v, the mass of water accelerated per unit time in the treading motion is given by (see Exercise 7-1) m Avw (7. The force producing this change in the momentum is applied to the water by the moving limbs. The kinetic energy given to the water each second is half the product of the mass accelerated each second and the squared nal velocity of the water. Note that, in our calculation, we have neglected the kinetic energy of the moving limbs. We can nd the percentage of the body volume X occupied by the porous bone that makes the average density of the sh be the same as the density of sea water (1. In sh that possess swim bladders, the decrease in density is provided by the gas in the bladder. Because the density of the gas is negligible compared to the density of tissue, the volume of the swim bladder required to reduce the density of the sh is smaller than that of the porous bone. For exam- ple, to achieve the density reduction calculated in the preceding example, the volume of the bladder is only about 4% of the total volume of the sh (see Exercise 7-6). The cuttlesh alters its density by injecting or withdrawing uid from its porous bone. Fish with swim bladders alter their density by changing the amount of gas in the bladder. A molecule in the interior of the liquid is surrounded by an equal number of neighboring molecules in all directions. Therefore, the net resultant inter- molecular force on an interior molecule is zero. Because there are no molecules above the surface, a molecule here is pulled predominantly in one direction, toward the interior of the surface. This causes the surface of a liquid to con- tract and behave somewhat like a stretched membrane. This contracting ten- dency results in a surface tension that resists an increase in the free surface of the liquid. It can be shown (see reference [7-7]) that surface tension is a force acting tangential to the surface, normal to a line of unit length on the surface (Fig. At the same time, however, these molecules are also subject to the attractive cohesive force exerted by the liquid, which pulls the molecules in the opposite direction.
Challenges of antibiotic development the global antibiotic resistance pandemic heralds a post antibiotic era as bad as the pre antibiotic era order pirfenex without a prescription. Cell wall synthesis inhibitors: lactam antibiotics lactam ring the lactam ring mimics the D-alanyl- D alanine portion of the peptide chain that is normally bound by pbps that assemble the peptidoglycan layer This prevents cross linking of the glycan strands leading to bacterial lysis Beta lactams penicillins cephalosporins carbapenems monobactams Natural penicillins Imipenem aztreonam Penicillin G Meropenem Penicillin V Ertapenem Benzathine P Procaine P Penicillinase R Methicillin Nafcillin st nd rd th th 1 gen 2 gen 3 gen 4 gen 5 gen Cloxacillin Cefadroxil Cefaclor Cefotaxime cefepime Ceftaroline aminopenicillins Cephalexin Cefamandole Ceftazidime ceftobiprole Amoxycillin Cephradine Cefuroxime ceftriaxone ampicillin cefazolin cefoxitin Extended spectrum Ticarcilin Piperacilin carbenicillin Spectrum of activity: Penicillins Natural penicillins Aminopenicillin/ B lactamase G+ve bacteria: streptococci cheap pirfenex line,L pirfenex 200mg with visa. Inhibitors monocytogenes some anaerobes, Sulbactam and clavulanate some spirochaetes, G-ve: inactivate the B lactamases and N. Epidermidis enterobacteriaceae, clostridia except Aminopenicillins difficile, Bacteroides spp Similar to natural penicillins with Extended spectrum additional G-ve:E. Spectrum of activity: Cephalosporins rd Each successive generation has 3 gen: in addition, activity against broader activity against aerobic G- B burgdorferi, greater activity nd ves. Influenza Used in combination treatment for mycobacterial infections Metronidazole Small molecule that can passively diffuse into bacteria. The use of radioactive material for certain in vitro clinical or laboratory testing may be authorized by a general license; however, that use may not involve internal or external administration of radioactive material, or the radiation to human beings or animals. Separate licenses are not normally issued to different departments of a hospital or to individuals employed by a hospital. Separate guidance has been developed to meet the specific needs of a teletherapy applicant. Information is considered relevant if it has the ability to change or affect an agency decision on issuing the license. A medical institution is an organization in which more than one medical discipline is practiced. In general, individual physicians or physician groups located within a licensed medical facility (e. Since a physician group does not normally have control over the facilities, the hospital remains responsible for activities conducted on its premises and must apply for the license. On specific licenses of limited scope, the authorized users are specifically listed in the license. In general, facilities for private and group practices do not include inpatient rooms and, therefore, procedures requiring hospitalization of the patient cannot be performed. A specific limited scope license may also be issued to an entity requesting to perform mobile medical services. A medical institution or a private or group practice may apply for authorization to use radioactive material in a mobile medical service. Medical institutions that provide patient care and conduct research programs that use radionuclides for in vitro, animal, and medical procedures may request a specific broad scope license. Research Involving Human Subjects Medical use is defined to include the administration of radioactive material or radiation incidental to the administration to human research subjects. Otherwise, the licensee must apply for a specific amendment and receive approval for the amendment before conducting such research. Whether or not a license amendment is required, licensees must obtain informed consent from human subjects and prior review and approval of the research activities by an Institutional Review Board in accordance with the meaning of those terms under the Federal Policy. Research involving human subjects shall be conducted only with radioactive materials listed in the license for the uses authorized in the license. Licensees are also required to review the content of the radiation protection program and its implementation at least annually. Even though the licensee may have filed for bankruptcy, the licensee remains responsible for compliance with all regulatory requirements. These records must, in part, identify all areas where licensed material is (or was) used or stored and any information relevant to spills (e. As an alternative to the potential need for site characterizations, some licensees prefer to maintain information on surveys and leak tests on an ongoing basis and as a low-cost means of providing evidence and assurance of an appropriate decommissioning status upon the termination of licensed activities and/or release of a site for non-licensed use. Licensees using sealed sources authorized generally use licensed material in a manner that would preclude releases into the environment, would not cause the activation of adjacent materials, or would not contaminate work areas. The licensees most recent leak test should demonstrate that there has been no leakage from the sealed sources while the sealed sources were in the licensees possession. Licensees authorized to possess radioactive material in excess of the limits specified in 4731. The requirements for financial assurance are specific to the types and quantities of radioactive material authorized on a license. Some medical use applicants and licensees may not need to take any action to comply with the financial assurance requirements because their total inventory of licensed material does not exceed the limits in 4731. Applicants requesting licensed material with a half-life in excess of 120 days should determine whether financial assurance is necessary. In addition, applicants requesting more than one radionuclide must use the sum-of-the-ratios method to determine if financial assurance is needed. Applications for authorization to possess and use unsealed radioactive material with a half-life exceeding 120 days must be accompanied by a decommissioning funding plan or certification of financial assurance when the trigger quantities given in 4731. Determining Need for Financial Assurance for Decommissioning The half-lives of unsealed radioactive material used by medical licensees have traditionally been less than 120 days. Therefore, most medical use applicants need only consider licensed material in sealed sources to evaluate the need for financial assurance. Use the following table as a worksheet to determine if financial assurance is required for the sealed sources listed. If requesting sealed sources other than those listed or any other unsealed radioactive material with a half-life greater than 120 days, refer to 4731. The sum of the fractions procedure is also depicted in the following table and must be used to determine the need for financial assurance for both sealed and unsealed radioactive material. If submittal of such information is necessary, please clearly specify the proprietary information. Failure to do so may result in disclosure of this information to the public or substantial delays in processing your application. Do not submit personal information about your individual employees unless it is necessary. For example, the training and experience of individuals should be submitted to demonstrate their ability to manage radiation safety programs or to work safely with radioactive materials. Home addresses and home telephone numbers should be submitted only if they are part of an emergency response plan. The statements and representations you make as if they were regulations will bind you. Check box B for an amendment to an existing license and provide the license number. An individual may be designated as the applicant only if the individual is acting in a private capacity and the use of the radioactive material is not connected with employment in a corporation or other legal entity. Item 3: Address(es) At Which Licensed Material Will Be Used or Possessed Applicants must provide a specific address for each location where radioactive material will be used or stored, or dispatched. A field station is a location where licensed material may be stored or used and from which the applicant will send material to jobsites. In addition, the applicant should state whether a location will be used only for storage of sources and devices. Item 4: Person to be Contacted About This Application Identify the individual who can answer questions about the application and include his or her telephone number. This notice is for information only and does not require a license amendment or a fee.
By W. Jorn. Lubbock Christian University.